Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated:  4/17/2017
Cleveland Clinic
mi
from
Cleveland, OH
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated: 4/17/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated:  4/17/2017
Geisinger Health
mi
from
Danville, PA
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated: 4/17/2017
Geisinger Health
mi
from
Danville, PA
Click here to add this to my saved trials
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated:  4/17/2017
Quest Diagnostics
mi
from
Horsham, PA
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated: 4/17/2017
Quest Diagnostics
mi
from
Horsham, PA
Click here to add this to my saved trials
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated:  4/17/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated: 4/17/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated:  4/17/2017
Baystate Health
mi
from
Springfield, MA
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated: 4/17/2017
Baystate Health
mi
from
Springfield, MA
Click here to add this to my saved trials
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated:  4/17/2017
Beaumont Health
mi
from
Royal Oak, MI
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated: 4/17/2017
Beaumont Health
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated:  4/17/2017
BioReference Labs
mi
from
Elmwood Park, NJ
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated: 4/17/2017
BioReference Labs
mi
from
Elmwood Park, NJ
Click here to add this to my saved trials
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated:  4/17/2017
MedFusion
mi
from
Lewisville, TX
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated: 4/17/2017
MedFusion
mi
from
Lewisville, TX
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
UCLA Clinical AIDS Research and Education (CARE) Center
mi
from
Los Angeles, CA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
UCLA Clinical AIDS Research and Education (CARE) Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Cancer Research Center of Hawaii
mi
from
Honolulu, HI
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Cancer Research Center of Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Boston University Cancer Research Center
mi
from
Boston, MA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Boston University Cancer Research Center
mi
from
Boston, MA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Baylor University Medical Center - Houston
mi
from
Houston, TX
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Baylor University Medical Center - Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Benaroya Research Institute at Virginia Mason Medical Center
mi
from
Seattle, WA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Benaroya Research Institute at Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
TMC207 +/- Rifabutin/Rifampin
A Phase I Open-Label Trial To Investigate the Pharmacokinetic Interaction Between Rifabutin Or Rifampin And A Single Dose Of TMC207 In Healthy Subjects
Status: Enrolling
Updated:  4/20/2017
Case Western Reserve University - Case Medical Center - Infectious Disease & HIV Medicine
mi
from
Cleveland, OH
TMC207 +/- Rifabutin/Rifampin
A Phase I Open-Label Trial To Investigate the Pharmacokinetic Interaction Between Rifabutin Or Rifampin And A Single Dose Of TMC207 In Healthy Subjects
Status: Enrolling
Updated: 4/20/2017
Case Western Reserve University - Case Medical Center - Infectious Disease & HIV Medicine
mi
from
Cleveland, OH
Click here to add this to my saved trials
Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B...
Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual Blood Stages of Plasmodium Falciparumc
Status: Enrolling
Updated:  4/20/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B...
Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual Blood Stages of Plasmodium Falciparumc
Status: Enrolling
Updated: 4/20/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Birmingham, AL
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Tuscaloosa, AL
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Jonesboro, AR
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Little Rock, AR
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Fountain Valley, CA
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Huntington Beach, CA
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Marietta, GA
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Woodstock, GA
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Woodstock, GA
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Bardstown, KY
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Bardstown, KY
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Crestview Hills, KY
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Louisville, KY
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Bossier City, LA
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Bossier City, LA
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Clyde, NC
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Clyde, NC
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Cleveland, OH
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Pittsburgh, PA
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
mi
from
Barnwell, SC
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
mi
from
Barnwell, SC
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Clarksville, TN
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Clarksville, TN
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Layton, UT
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Layton, UT
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Orem, UT
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Orem, UT
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
mi
from
Springville, UT
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
mi
from
Springville, UT
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Midlothian, VA
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Midlothian, VA
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Spokane, WA
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated:  4/24/2017
Clinical Research Facility
mi
from
Fort Worth, TX
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) Administered in Infants and Toddlers
Status: Enrolling
Updated: 4/24/2017
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated:  4/25/2017
Boston Med Ctr
mi
from
Boston, MA
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated: 4/25/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer
A Phase II Trial of Hyperthermia and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate
Status: Enrolling
Updated:  4/25/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer
A Phase II Trial of Hyperthermia and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate
Status: Enrolling
Updated: 4/25/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic Encephalopathy
A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy Of Rifaximin 550 Mg With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy
Status: Enrolling
Updated:  4/26/2017
Banner Research
mi
from
Phoenix, AZ
The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic Encephalopathy
A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy Of Rifaximin 550 Mg With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy
Status: Enrolling
Updated: 4/26/2017
Banner Research
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic Encephalopathy
A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy Of Rifaximin 550 Mg With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy
Status: Enrolling
Updated:  4/26/2017
Southern California Liver Centers
mi
from
Coronado, CA
The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic Encephalopathy
A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy Of Rifaximin 550 Mg With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy
Status: Enrolling
Updated: 4/26/2017
Southern California Liver Centers
mi
from
Coronado, CA
Click here to add this to my saved trials
The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic Encephalopathy
A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy Of Rifaximin 550 Mg With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy
Status: Enrolling
Updated:  4/26/2017
UCSF/Fresno - CRMC
mi
from
Fresno, CA
The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic Encephalopathy
A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy Of Rifaximin 550 Mg With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy
Status: Enrolling
Updated: 4/26/2017
UCSF/Fresno - CRMC
mi
from
Fresno, CA
Click here to add this to my saved trials
The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic Encephalopathy
A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy Of Rifaximin 550 Mg With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy
Status: Enrolling
Updated:  4/26/2017
UCSD Clinical & Translational Research Institute
mi
from
La Jolla, CA
The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic Encephalopathy
A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy Of Rifaximin 550 Mg With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy
Status: Enrolling
Updated: 4/26/2017
UCSD Clinical & Translational Research Institute
mi
from
La Jolla, CA
Click here to add this to my saved trials
The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic Encephalopathy
A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy Of Rifaximin 550 Mg With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy
Status: Enrolling
Updated:  4/26/2017
Salix Site
mi
from
Long Beach, CA
The Safety/Efficacy Of Rifaximin With/Without Lactulose In Subjects With A History Of Recurrent Hepatic Encephalopathy
A Multicenter, Randomized, Open-Label, Active-Controlled, Trial To Evaluate The Safety And Efficacy Of Rifaximin 550 Mg With And Without Lactulose In Subjects With A History Of Recurrent Overt Hepatic Encephalopathy
Status: Enrolling
Updated: 4/26/2017
Salix Site
mi
from
Long Beach, CA
Click here to add this to my saved trials